Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β‐catenin/ZEB1 axis

Colorectal cancer (CRC) is a recurring cancer that is often resistant to conventional therapies and therefore requires the development of molecular‐based therapeutic approaches. Dopamine receptor D2 (DRD2) is associated with the growth of many types of tumors, but its oncogenic role in CRC is unclea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyunjung, Shim, Sehwan, Kong, Joon Seog, Kim, Min‐Jung, Park, Sunhoo, Lee, Seung‐Sook, Kim, Areumnuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409418/
https://www.ncbi.nlm.nih.gov/pubmed/34118099
http://dx.doi.org/10.1111/cas.15026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409418/
https://www.ncbi.nlm.nih.gov/pubmed/34118099
http://dx.doi.org/10.1111/cas.15026

Ejemplares similares